Header Logo

EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.

EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol. 1993 Aug; 16(4):342-5.

View in: PubMed